Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx
- PMID: 1679639
- DOI: 10.1007/BF00176755
Proto-oncogene allelic variations in human squamous cell carcinomas of the larynx
Abstract
Proto-oncogene restriction fragment length polymorphisms (RFLPs) were investigated in a group of 23 patients with squamous cell carcinomas of the larynx. The frequency of the rare 5 kb c-mos allele was significantly higher than that observed in control groups of patients with colorectal neoplasms or lymphoproliferative disorders. In addition, the 2 patients heterozygous at the c-mos locus (TC-8 and TC-10) were the only 2 of our series of develop multiple malignancies. Also, the 10 kb L-myc allele was remarkably more represented in patients with laryngeal carcinoma when compared to controls. These findings suggest that c-mos and L-myc RFLPs might be helpful in identifying those individuals who are at a higher risk of developing laryngeal carcinomas. Single allele amplification of L-myc, c-myb and c-mos proto-oncogenes, with no concomitant mRNA hyperexpression, were observed in 3 cases. The results obtained seem to rule out a direct pathogenetic role of these proto-oncogenes and suggest that the amplification of other closely linked genes, located on chromosomes 1, 6 and 8, respectively, may be causally associated with the development of these tumors. No allelic deletions at the c-myb locus were observed, whereas a loss of a c-Ha-ras-1 allele was demonstrated in one of the 11 heterozygous patients. Thus, the analysis of polymorphic proto-oncogenes in laryngeal carcinomas allowed us to identify a group of genetic abnormalities (chromosomes 1, 6 and 8 gene amplifications and c-Ha-ras-1 deletions) which may be involved in the development or progression of these tumors.
Similar articles
-
Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.Cancer Res. 1989 Dec 1;49(23):6675-9. Cancer Res. 1989. PMID: 2573420
-
Loss of Harvey ras heterozygosity in oral squamous carcinoma.J Oral Pathol Med. 1989 Feb;18(2):79-83. doi: 10.1111/j.1600-0714.1989.tb00741.x. J Oral Pathol Med. 1989. PMID: 2568483
-
Oncogene amplifications, rearrangements, and restriction fragment length polymorphisms in human leukaemia.Eur J Cancer Clin Oncol. 1987 Jun;23(6):623-9. doi: 10.1016/0277-5379(87)90257-4. Eur J Cancer Clin Oncol. 1987. PMID: 2888656
-
Genetic variability of proto-oncogenes for breast cancer risk and prognosis.Biochimie. 1988 Jul;70(7):951-9. doi: 10.1016/0300-9084(88)90237-4. Biochimie. 1988. PMID: 2905174 Review.
-
Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.Am Rev Respir Dis. 1990 Dec;142(6 Pt 2):S20-6. doi: 10.1164/ajrccm/142.6_Pt_2.S20. Am Rev Respir Dis. 1990. PMID: 2174659 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials